Secondary gliosarcoma after diagnosis of glioblastoma: Clinical experience with 30 consecutive patients

Journal of Neurosurgery

Volumn 112, Issue 5, 2010, Pages 990-996

  Han, Seunggu J ^a   Yang, Isaac ^a   Otero, Jose J ^a   Ahn, Brian J ^a   Tihan, Tarik ^a   McDermott, Michael W ^a   Berger, Mitchel S ^a   Chang, Susan M ^a   Parsa, Andrew T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glioblastoma multiforme; Outcome analysis; Secondary gliosarcoma

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CARMUSTINE; ERLOTINIB; IRINOTECAN; TAMOXIFEN; TEMOZOLOMIDE;

ADULT; ARTICLE; CANCER THERAPY; CLINICAL ARTICLE; FEMALE; GLIOBLASTOMA; GLIOSARCOMA; HISTOPATHOLOGY; HUMAN; MALE; PRIORITY JOURNAL; SURVIVAL; TUMOR GROWTH; WORLD HEALTH ORGANIZATION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; FEMALE; GLIOBLASTOMA; GLIOSARCOMA; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 77952077078     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2009.9.JNS09931     Document Type: Article

References (25)

1. Actor B, Cobbers JM, Buschges R, Wolter M, Knobbe CB, Lichter P, et al: Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components. Genes Chromosomes Cancer 34:416-427, 2002 (Pubitemid 34787463)
2. Beaumont TL, Kupsky WJ, Barger GR, Sloan AE: Glioblastoma with multiple extracranial metastases: case report and review of literature. J Neurooncol 83:39-46, 2007 (Pubitemid 46647163)
3. Biernat W, Aguzzi A, Sure U, Grant JW, Kleihues P, Hegi ME: Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells. J Neuropathol Exp Neurol 54:651-656, 1995
4. Cervoni L, Celli P: Cerebral gliosarcoma: prognostic factors. Neurosurg Rev 19:93-96, 1996
5. Deb P, Sharma MC, Chander B, Mahapatra AK, Sarkar C: Giant cell glioblastoma multiforme: report of a case with prolonged survival and transformation to gliosarcoma. Childs Nerv Syst 22:314-319, 2006 (Pubitemid 43298750)
6. Feigin I, Gross SW: Sarcoma arising in glioblastoma of the brain. Am J Pathol 31:633-653, 1955
7. Galanis E, Buckner JC, Dinapoli RP, Scheithauer BW, Jenkins RB, Wang CH, et al: Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results. J Neurosurg 89:425-430, 1998 (Pubitemid 28405257)
8. Han S, Yang I, Tihan T, Prados MD, Parsa AT: Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity. J Neu rooncol [epub ahead of print], 2009
9. Han SJ, Yang I, Tihan T, Chang SM, Parsa AT: Secondary gliosarcoma: a review of clinical features and pathologic diagnosis. J Neurosurg [epub ahead of print], 2009
10. Kozak KR, Mahadevan A, Moody JS: Adult gliosarcoma: epidemiology, natural history, and factors associated with outcome. Neuro-oncol 11:183-191, 2009
11. Lieberman KA, Fuller CE, Caruso RD, Schelper RL: Postradiation gliosarcoma with osteosarcomatous components. Neu roradiology 43:555-558, 2001
12. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109, 2007
13. Lutterbach J, Guttenberger R, Pagenstecher A: Gliosarcoma: a clinical study. Radiother Oncol 61:57-64, 2001
14. Maiuri F, Stella L, Benvenuti D, Giamundo A, Pettinato G: Cere bral gliosarcomas: correlation of computed tomographic findings, surgical aspect, pathological features, and prognosis. Neurosurgery 26:261-267, 1990 (Pubitemid 20091251)
15. Meis JM, Martz KL, Nelson JS: Mixed glioblastoma multiforme and sarcoma: a clinicopathologic study of 26 Radiation Therapy Oncology Group Cases. Cancer 67:2342-2349, 1991
16. Miller CR, Perry A: Glioblastoma: morphologic and molecular genetic diversity. Arch Pathol Lab Med 131:397-406, 2007 (Pubitemid 46365522)
17. Morantz RA, Feigin I, Ransohoff J: Clinical and pathological study of 24 cases of gliosarcoma. J Neurosurg 45:398-408, 1976
18. Parekh HC, O'Donovan DG, Sharma RR, Keogh AJ: Primary cerebral gliosarcoma: report of 17 cases. Br J Neurosurg 9: 171-178, 1995
19. Perry JR, Ang LC, Bilbao JM, Muller PJ: Clinicopathologic features of primary and postirradiation cerebral gliosarcoma. Cancer 75:2910-2918, 1995
20. Rodriguez FJ, Scheithauer BW, Giannini C, Bryant SC, Jenkins RB: Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study. Cancer 113:2779-2789, 2008
21. Salvati M, Caroli E, Raco A, Giangaspero F, Delfini R, Ferrante L: Gliosarcomas: analysis of 11 cases do two subtypes exist? J Neurooncol 74:59-63, 2005 (Pubitemid 41194532)
22. Sarkar C, Sharma MC, Sudha K, Gaikwad S, Varma A: A clin icopathological study of 29 cases of gliosarcoma with special reference to two unique variants. Indian J Med Res 106: 229-235, 1997 (Pubitemid 27450259)
23. Slowik F, Balogh I: Extracranial spreading of glioblastoma multiforme. Zentralbl Neurochir 41:57-68, 1980
24. Stupp R, Mason WP, Van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005 (Pubitemid 40349501)
25. Weaver D, Vandenberg S, Park TS, Jane JA: Selective peripancreatic sarcoma metastases from primary gliosarcoma. J Neurosurg 61:599-601, 1984 (Pubitemid 14065120)